Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis - PubMed (original) (raw)
Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis
K A Khan et al. Lung. 2015 Feb.
Abstract
Introduction: Despite advances in diagnosis and management, the outcomes for both lung cancer and idiopathic pulmonary fibrosis (IPF) are still unfavourable. The pathophysiology and outcomes for patients with concomitant lung cancer and IPF remains unclear.
Methodology: A retrospective analysis was performed of all patients presenting with concomitant IPF and lung cancer to our centre over a 3-year period. Patients with connective tissue disease, asbestos exposure, sarcoidosis, previous thoracic radiation, radiological evidence of fibrosis but no histological confirmation of lung cancer, or the use of medications known to cause pulmonary fibrosis were excluded. We describe clinical, radiological and pathological characteristics of this group. We also report the response to standardized lung cancer therapy in this cohort.
Results: Of 637 lung cancer patients, 34 were identified with concomitant IPF (5.3 %) and all were smokers. 85 % had non-small cell lung cancer, 41 % were squamous cell cancers. The majority of tumours were located in the lower lobes, peripheral and present in an area of honeycombing. Despite the fact that approximately 2/3rds of the patients had localised or locally advanced lung cancer, the outcome of therapy for lung cancer was extremely poor regardless of tumour stage or severity of IPF.
Conclusions: At our centre, 1/20 patients with lung cancer have concomitant IPF. The majority of these tumours are small in size, peripheral in location and squamous cell carcinoma; in an area of honey combing. The outcome for concomitant lung cancer and IPF regardless of stage or therapy is poor.
Similar articles
- Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection.
Nezka H, Igor P, Izidor K. Nezka H, et al. Radiol Oncol. 2019 Sep 24;53(3):357-361. doi: 10.2478/raon-2019-0032. Radiol Oncol. 2019. PMID: 31553706 Free PMC article. - Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Sato S, Koike T, Hashimoto T, Ishikawa H, Okada A, Watanabe T, Tsuchida M. Sato S, et al. Ann Thorac Cardiovasc Surg. 2016 Aug 23;22(4):216-23. doi: 10.5761/atcs.oa.15-00315. Epub 2016 Apr 5. Ann Thorac Cardiovasc Surg. 2016. PMID: 27052999 Free PMC article. - Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
Lee T, Park JY, Lee HY, Cho YJ, Yoon HI, Lee JH, Jheon S, Lee CT, Park JS. Lee T, et al. Respir Med. 2014 Oct;108(10):1549-55. doi: 10.1016/j.rmed.2014.07.020. Epub 2014 Aug 15. Respir Med. 2014. PMID: 25175479 - Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review.
Ma W, Li H, Tian Z, Wang S, Zheng X, Hou J. Ma W, et al. BMC Pulm Med. 2020 Mar 20;20(1):69. doi: 10.1186/s12890-020-1094-1. BMC Pulm Med. 2020. PMID: 32197657 Free PMC article. Review. - IPF, comorbidities and management implications.
Vancheri C, Cottin V, Kreuter M, Hilberg O. Vancheri C, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:17-23. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237439 Review.
Cited by
- Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Q, An N, Liu Y, Zhu Y, Pan W, Gu P, Zhao J, Pu Q, Zhu W. Zhang Q, et al. Front Oncol. 2024 Sep 13;14:1448379. doi: 10.3389/fonc.2024.1448379. eCollection 2024. Front Oncol. 2024. PMID: 39346732 Free PMC article. - Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis.
Otoshi R, Ikeda S, Kaneko T, Sagawa S, Yamada C, Kumagai K, Moriuchi A, Sekine A, Baba T, Ogura T. Otoshi R, et al. Cancers (Basel). 2024 Apr 29;16(9):1734. doi: 10.3390/cancers16091734. Cancers (Basel). 2024. PMID: 38730686 Free PMC article. Review. - Clinicoradiological outcomes after radical radiotherapy for lung cancer in patients with interstitial lung disease.
Walls GM, McMahon M, Moore N, Nicol P, Bradley G, Whitten G, Young L, O'Hare JM, Lindsay J, Connolly R, Linden D, Ball PA, Hanna GG, McAleese J. Walls GM, et al. BJR Open. 2023 Apr 19;5(1):20220049. doi: 10.1259/bjro.20220049. eCollection 2023. BJR Open. 2023. PMID: 37389005 Free PMC article. - Association between idiopathic pulmonary fibrosis and risk of different pathological types of lung cancer: a Mendelian randomization study.
Zheng H, Nie D, Huang X. Zheng H, et al. J Cancer Res Clin Oncol. 2023 Aug;149(10):7751-7757. doi: 10.1007/s00432-023-04727-w. Epub 2023 Apr 3. J Cancer Res Clin Oncol. 2023. PMID: 37009919 - Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges.
Abu Qubo A, Numan J, Snijder J, Padilla M, Austin JHM, Capaccione KM, Pernia M, Bustamante J, O'Connor T, Salvatore MM. Abu Qubo A, et al. Breathe (Sheff). 2022 Dec;18(4):220147. doi: 10.1183/20734735.0147-2022. Epub 2023 Jan 10. Breathe (Sheff). 2022. PMID: 36865932 Free PMC article. Review.
References
- Eur Respir J. 2013 Feb;41(2):262-9 - PubMed
- Am J Respir Cell Mol Biol. 2000 May;22(5):628-34 - PubMed
- J Comput Assist Tomogr. 1996 Nov-Dec;20(6):979-82 - PubMed
- Lung Cancer. 1999 Dec;26(3):169-74 - PubMed
- Eur Respir J. 2010 Mar;35(3):496-504 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical